You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,664,187


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,664,187 protect, and when does it expire?

Patent 8,664,187 protects TOBI PODHALER and is included in one NDA.

This patent has thirty patent family members in twenty-five countries.

Summary for Patent: 8,664,187
Title:Methods of treatment of endobronchial infections
Abstract: The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
Inventor(s): Challoner; Peter (Emeryville, CA), Rodriguez; Carlos (Emeryville, CA), Samara; Emil (Emeryville, CA), Tarara; Thomas E (Burlingame, CA), Lord; John D (San Carlos, CA)
Assignee: Novartis AG (Basel, CH)
Application Number:13/404,359
Patent Claim Types:
see list of patent claims
Use; Formulation; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,664,187

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, potential infringement, and overall impact on the market. This article will delve into the details of United States Patent 8,664,187, exploring its claims, the patent landscape, and the tools and resources available for such an analysis.

Understanding the Patent

Title and Abstract

United States Patent 8,664,187, titled "Pulmonary Delivery of Aminoglycoside," pertains to methods and devices for delivering aminoglycoside antibiotics directly to the lungs. The abstract typically provides a brief overview of the invention, including the problem it solves and the key elements of the solution.

Claims Analysis

Independent and Dependent Claims

The claims section of a patent is the most critical part, as it defines the scope of the invention. Independent claims stand alone and define the broadest scope of the invention, while dependent claims build upon the independent claims and narrow the scope further. For example, Claim 1 might describe the overall method of pulmonary delivery, while Claim 2 might specify a particular formulation of the aminoglycoside used in that method[5].

Claim Construction

Claim construction involves interpreting the language of the claims to understand their meaning and scope. This process is often crucial in patent litigation, as it determines what the patentee is entitled to protect. For instance, if a claim uses a term like "aminoglycoside antibiotic," the court might need to define what specific compounds fall under this category[2].

Patent Landscape

Prior Art and Novelty

To understand the patent landscape, it is essential to identify prior art that may have influenced the invention or could potentially invalidate it. Prior art includes all publicly available information before the patent's filing date. Tools like the USPTO's Patent Public Search and international databases such as the European Patent Office's esp@cenet can be used to search for prior art[1].

Related Patents and Patent Families

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including all related applications filed at participating IP Offices. This can help in identifying similar inventions and understanding the broader patent landscape[1].

Tools and Resources for Patent Analysis

USPTO Resources

  • Patent Public Search: This tool offers enhanced access to prior art and is a powerful resource for conducting comprehensive patent searches[1].
  • Global Dossier: Provides access to file histories of related applications from participating IP Offices, helping in understanding the global patent family[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques, which can be invaluable for detailed analysis[1].

International Patent Databases

  • European Patent Office (EPO): The esp@cenet network provides access to Europe's patent databases and includes machine translations for some languages[1].
  • World Intellectual Property Organization (WIPO): The PATENTSCOPE® Search Service offers full-text search of published international patent applications and machine translations for some documents[1].

Statistical Analysis and Datasets

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset contains detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. This dataset can be used to analyze trends in patent scope and claim construction over time[3].

Legal and Litigation Aspects

Patent Infringement and Validity

In the context of patent litigation, understanding the claims and scope of a patent is crucial. For example, in the case of Mobile Acuity Ltd. v. Blippar Ltd., the court's interpretation of the claims' scope led to a determination of patent invalidity under § 101 of the US patent law[2].

Best Practices for Conducting a Preliminary Patent Search

Step-by-Step Strategy

The USPTO provides a step-by-step strategy for conducting a preliminary patent search, which includes using multiple search tools, understanding classification systems, and reviewing the Official Gazette for issued patents[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating IP5 Offices for the family members of a patent application. This tool helps in visualizing search results from multiple offices on a single page, making it easier to identify potential prior art[1].

Sequence Listings and Mega Items

For patents involving biological sequences, the Publication Site for Issued and Published Sequences (PSIPS) provides access to sequence listings, tables, and other mega items. This is particularly relevant for patents like 8,664,187, which may involve specific formulations or biological compounds[1].

Patent Assignment and Ownership

The Patent Assignment Search website allows users to search for patent assignments and changes in ownership. This is important for understanding the current ownership and any potential licensing or litigation issues related to the patent[1].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Patent Landscape: Identifying prior art and related patents helps in understanding the novelty and non-obviousness of the invention.
  • Tools and Resources: Utilizing USPTO resources, international patent databases, and statistical datasets can enhance the accuracy and depth of the analysis.
  • Legal Considerations: Interpreting claims in the context of patent law and litigation is vital for determining validity and infringement.

FAQs

  1. What is the purpose of the Global Dossier service?

    • The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to view the patent family for a specific application and understand the global patent landscape[1].
  2. How can I search for prior art related to a patent?

    • You can use the USPTO's Patent Public Search tool, international databases like the EPO's esp@cenet, and other resources to search for prior art that may have influenced the invention or could potentially invalidate it[1].
  3. What is the significance of the Patent Claims Research Dataset?

    • The Patent Claims Research Dataset contains detailed information on claims from US patents and applications, allowing for the analysis of trends in patent scope and claim construction over time[3].
  4. How do I determine the current ownership of a patent?

    • You can use the Patent Assignment Search website to search for patent assignments and changes in ownership[1].
  5. What is the role of the Common Citation Document (CCD) in patent searching?

    • The CCD consolidates prior art cited by all participating IP5 Offices for the family members of a patent application, helping to visualize search results from multiple offices on a single page[1].

Sources

  1. USPTO - Search for patents
  2. CAFC - MOBILE ACUITY LTD. v. BLIPPAR LTD.
  3. USPTO - Patent Claims Research Dataset
  4. Federal Register - Request for Comments on USPTO Initiatives
  5. Unified Patents Portal - US-6946339-B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,664,187

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Speciality Lp TOBI PODHALER tobramycin POWDER;INHALATION 201688-001 Mar 22, 2013 RX Yes Yes 8,664,187 ⤷  Subscribe TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,664,187

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005258078 ⤷  Subscribe
Brazil PI0512146 ⤷  Subscribe
Canada 2570976 ⤷  Subscribe
China 101014320 ⤷  Subscribe
Cyprus 1113562 ⤷  Subscribe
Denmark 1765288 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.